國家衛生研究院 NHRI:Item 3990099045/6309
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 910684      在线人数 : 870
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/6309


    题名: Prodigiosin down-regulates SKP2 to induce p27KIP1 stabilization and antiproliferation in human lung adenocarcinoma cells
    作者: Hsieh, HY;Shieh, JJ;Chen, CJ;Pan, MY;Yang, SY;Lin, SC;Chang, JS;Lee, AY;Chang, CC
    贡献者: National Institute of Cancer Research
    摘要: Background and purpose: High levels of SKP2 are a poor prognostic factor in multiple human cancers and mostly correlate with low p27(KIP1) levels. Prodigiosin is a bacterial tripyrrole pigment with strong proapoptotic activity. Induction of cell cycle blockade underlies one of prodigiosin's anticancer action with unclear mechanisms. The aim of this study was to explore the role of the SKP2-p27(KIP1) axis in prodigiosin's cytostatic effect on human lung adenocarcinoma cells. Experimental approach: Prodigiosin's effects on cell cycle progression and long-term cell proliferation of human lung adenocarcinoma cells were characterized by flow cytometry and colony formation assay, respectively. Real-time RT-PCR and promoter activity analyses were performed for assessing transcriptional control, while cycloheximide chase analysis for protein stability evaluation. Immunoblotting were employed for mechanistic study. Key results: Prodigiosin increased p27(KIP1) expression mainly by stabilizing p27(KIP1) through transcriptional repression of SKP2. Importantly, SKP2 overexpression or p27(KIP1) depletion restored colony formation capacity of prodigiosin-treated cells. Furthermore, prodigiosin induced AKT dephosphorylation, leading to AKT inhibition as revealed by decreased serine 9 phopshorylation of GSK-3beta. Constitutive AKT activation nearly abroagted prodigiosin-induced SKP2 repression. Additionally, prodigiosin down-regulated E2F1, previously reported to mediate PI3K/AKT-induced SKP2 transcription. However, E2F1 overexpression failed to restore SKP2 expression in prodigiosin-treated cells. Conclusions and implications: Transcriptional repression of SKP2 and the consequent accumulation of p27(KIP1) are indispensable for prodigiosin's antiproliferative action. Mechanistically, prodigiosin induces AKT inhibition to down-regulate SKP2 in GSK-3beta- and E2F1-independent manners. Our findings further implicate the potential for developing prodigiosin as a novel class of SKP2-targeting anticancer agent.
    日期: 2012-08
    關聯: British Journal of Pharmacology. 2012 Aug;166(7):2095-2108.
    Link to: http://dx.doi.org/10.1111/j.1476-5381.2012.01921.x
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0007-1188&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000306186700011
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84862215651
    显示于类别:[李岳倫] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    PUB22372491.pdf1391KbAdobe PDF664检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈